Electrophysiology Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Electrophysiology Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Electrophysiology Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Electrophysiology Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Electrophysiology equipment analyzes the electrical activity of the heart. The equipment is used with cardiac catheters and sophisticated computers to generate electrocardiogram (EKG) tracings and electrical measurements with exquisite precision from within the heart chambers.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Electrophysiology Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Electrophysiology Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Electrophysiology Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 Table of Contents
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Electrophysiology Devices Overview
4 Products under Development
4.1 Electrophysiology Devices - Pipeline Products by Stage of Development
4.2 Electrophysiology Devices - Pipeline Products by Segment
4.3 Electrophysiology Devices - Pipeline Products by Territory
4.4 Electrophysiology Devices - Pipeline Products by Regulatory Path
4.5 Electrophysiology Devices - Pipeline Products by Estimated Approval Date
Table 15: Ablamap System - A Randomized Controlled Study to Evaluate the Reliability of the Ablacon Electrographic FLOW (EGF) Algorithm Technology (Ablamap Software) to Identify AF Sources and Guide Ablation Therapy in Patients with Persistent Atrial Fibrillation
Table 16: AccuPulse Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 17: D Cardiac Electroanatomic Mapping System - Product Status
Table 18: D Cardiac Electroanatomic Mapping System - Product Description
Table 71: Berlin Heals GmbH - Ongoing Clinical Trials Overview
Table 72: C-MIC Device - Early Feasibility Study of C-MIC Heart Failure Device
Table 73: C-MIC Device - Prospective, Randomized, Open, Comparison Study to Demonstrate the Performance and the Safety of Cardiac Microcurrent Therapy (C-MIC) System
Table 74: C-MIC Device - The C-MIC-II Follow-Up Study
Table 89: Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter - Implementation of the HELIOSTAR in Real-world Clinical Practice at a High-volume Center - Operator Learning Curve and Procedural Outcome Parameters
Table 91: THERMOCOOL SMARTTOUCH SF-5D Catheter - Evaluation of the Safety and Performance of the Very High Power-short Duration QDOT Strategy in Patients Referred for Atrial Fibrillation Ablation
Table 92: TRUPULSE Generator - Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System (AdmIRE)
Table 93: TRUPULSE Generator - Pulsed Field Ablation (PFA) System for the Treatment of Paroxysmal Atrial Fibrillation (PAF) by Irreversible Electroporation (IRE)
Table 94: TRUPULSE Generator - Safety and Effectiveness Evaluation of the THERMOCOOL SMARTTOUCH SF Catheter With the TRUPULSE Generator for Treatment of Paroxysmal Atrial Fibrillation (PAF)
Table 122: ElePulse System - Rapid One-Shot Electroporation Trial For Atrial Fibrillation: Reset-AF: Investigating the Effect of A Novel Intervention on Atrial Fibrillation Recurrence
Table 123: Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 7